Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.4), the stock would be worth $2.87 (14% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.6 | $3.32 |
0%
|
| 3-Year Average | 1.4 | $2.87 |
-14%
|
| 5-Year Average | 1.4 | $2.92 |
-12%
|
| Industry Average | 1.2 | $2.58 |
-22%
|
| Country Average | 3 | $6.34 |
+91%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
$25.1m
|
/ |
Jan 2026
$18.8m
|
= |
|
|
$25.1m
|
/ |
Dec 2026
$20.9m
|
= |
|
|
$25.1m
|
/ |
Dec 2027
$23.3m
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Nephros Inc
NASDAQ:NEPH
|
35.3m USD | 1.6 | 29.6 | |
| JP |
|
Fujitsu General Ltd
TSE:6755
|
4 282 616.6T JPY | 12 107 466 | -3 733 754 630.9 | |
| CN |
|
Midea Group Co Ltd
SZSE:000333
|
611.2B CNY | 1 | 14.1 | |
| CN |
|
Gree Electric Appliances Inc of Zhuhai
SZSE:000651
|
215.3B CNY | 0.7 | 6.8 | |
| CN |
|
Haier Smart Home Co Ltd
SSE:600690
|
200.1B CNY | 0.6 | 10.2 | |
| US |
S
|
Sharkninja Inc
NYSE:SN
|
16.2B USD | 2.5 | 23.1 | |
| IN |
|
LG Electronics India Ltd
NSE:LGEINDIA
|
1.1T INR | 6.3 | 110 | |
| IT |
|
De' Longhi SpA
MIL:DLG
|
5.1B EUR | 1.1 | 15.8 | |
| CN |
E
|
Ecovacs Robotics Co Ltd
SSE:603486
|
38.8B CNY | 2.5 | 28.8 | |
| CN |
|
Zhejiang Supor Co Ltd
SZSE:002032
|
38B CNY | 1.5 | 18.2 | |
| CN |
H
|
Hangzhou Greatstar Industrial Co Ltd
SZSE:002444
|
39B CNY | 2.3 | 15.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 3 |
| 70th Percentile | 5.3 |
| Max | 4 613 320.1 |
Other Multiples
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
